Picture of Rezolute logo

RZLT — Rezolute Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Annual cashflow statement for Rezolute, fiscal year end - June 30th, USD millions except per share, conversion factor applied.

2022
June 30th
2023
June 30th
2024
June 30th
2025
June 30th
2026
June 30th
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-41.1-51.8-68.5-74.4-77.6
Depreciation
Non-Cash Items1.776.257.965.2612.6
Unusual Items
Other Non-Cash Items
Changes in Working Capital-0.3421.023.10.0470.33
Change in Prepaid Expenses
Change in Accounts Payable
Change in Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities-39.6-44.5-57.4-69.1-64.6
Capital Expenditures—-0.153———
Purchase of Fixed Assets
Other Investing Cash Flow Items—-10148.7-14.5-21.1
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities—-10148.7-14.5-21.1
Financing Cash Flow Items-20-0.759-0.315-1.06-0.035
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities14911.6631072.24
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash109-13454.423.7-83.5